CHAI CHRISTOPHER Y 4
4 · Principia Biopharma Inc. · Filed Aug 20, 2020
Insider Transaction Report
Form 4
CHAI CHRISTOPHER Y
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-08-18$99.37/sh−7,500$745,240→ 3,539 total - Exercise/Conversion
Common Stock
2020-08-18$3.00/sh+7,500$22,483→ 11,039 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-08-18−7,500→ 56,982 totalExercise: $3.00Exp: 2023-12-11→ Common Stock (7,500 underlying)
Holdings
- 3,302(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $99.28 to $99.50 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]Shares indirectly held by Christopher Chai, as custodian for his children under California Uniform Transfer to Minors Act, of which the Reporting Person is a custodian and may be deemed to share voting and dispositive power over these shares.
- [F4]The stock option is fully vested and immediately exercisable.